SEI INVESTMENTS CO - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$300,786
-47.7%
11,194
-30.6%
0.00%0.0%
Q2 2023$574,879
+23.8%
16,121
+40.8%
0.00%0.0%
Q4 2022$464,290
+18.7%
11,447
-3.2%
0.00%0.0%
Q3 2022$391,000
+18.1%
11,820
+25.9%
0.00%0.0%
Q2 2022$331,000
-24.4%
9,390
-1.5%
0.00%0.0%
Q1 2022$438,000
-50.3%
9,534
-28.3%
0.00%
-50.0%
Q4 2021$881,000
+4.0%
13,291
-2.0%
0.00%0.0%
Q3 2021$847,000
-25.8%
13,561
-1.7%
0.00%
-33.3%
Q2 2021$1,142,000
-42.9%
13,790
-50.7%
0.00%
-40.0%
Q1 2021$2,001,000
-8.9%
27,984
-2.2%
0.01%
-16.7%
Q4 2020$2,196,000
+237.8%
28,619
+89.5%
0.01%
+200.0%
Q3 2020$650,000
+40.1%
15,104
+40.7%
0.00%
+100.0%
Q2 2020$464,000
-59.7%
10,734
-40.9%
0.00%
-66.7%
Q4 2019$1,151,000
+70.0%
18,150
-24.5%
0.00%
+50.0%
Q3 2019$677,00024,0360.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders